6-pyrimidinyl-pyrimid-2-one derivative

Details for Australian Patent Application No. 2008297817 (hide)

Owner MITSUBISHI TANABE PHARMA CORPORATION SANOFI-AVENTIS

Inventors Barneoud, Pascal; Benavides, Jesus; Fukunaga, Kenji; Pratt, Jeremy; Watanabe, Kazutoshi

Agent Collison & Co

Pub. Number AU-A-2008297817

PCT Pub. Number WO2009/035162

Priority 2007-269485 14.09.07 JP; 2007-275713 25.09.07 JP; 08290028.3 11.01.08 EP

Filing date 12 September 2008

Wipo publication date 19 March 2009

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

22 April 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read 6-pyrimidinyl-pyrimid-4-one derivative

22 April 2010 PCT application entered the National Phase

  PCT publication WO2009/035162 Priority application(s): WO2009/035162

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008297839-Antenna sheet, transponder and book form

2008297814-3-methyl-2- ( (2s) -2- (4- (3-methyl-l, 2, 4-0xadiaz0l-5-yl) phenyl) morpholino) - 6- (pyrimidin-4-yl) pyrimidin-4 (3H) -one as tau protein kinase inhibitor